Shuttle Pharmaceuticals to Present at Lytham Partners Investor Select Conference on January 31
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH), a pharmaceutical company dedicated to enhancing cancer treatment outcomes, announced that CEO Anatoly Dritschilo will present at the Lytham Partners Investor Select Conference on January 31, 2023. This virtual event will include one-on-one meetings with investors, providing a platform for discussion on the company's mission to improve radiation therapy efficacy while minimizing side effects. A webcast of the presentation will be available at 9:00 AM ET on the same day, with a replay option afterward. For more details, visit their website.
Details
News Market Reaction – SHPH
The recorded move for SHPH in the trading session of this news was +1.48%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company Webcast
The Company's webcast presentation will be available for viewing at
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact
About
Founded in 2012 by faculty members of the Georgetown University Medical Center,
Safe Harbor Statement
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements concerning the development of our company. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including factors discussed in the "Risk Factors" section of Shuttle Pharma's IPO prospectus filed with the
240-403-4212
info@shuttlepharma.com
Investor Contacts
Lytham
602-889-9700
shph@lythampartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shuttle-pharmaceuticals-to-present-at-lytham-partners-investor-select-conference-on-january-31-301731807.html
SOURCE
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.